Isolation and Characterization of a Klebsiella Phage H33IIK Targeting Multidrug-Resistant Klebsiella pneumoniae in Peru
Antibiotics · 01.04.2026 · 15 (4) · 365
DOI: 10.3390/antibiotics15040365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 01.04.2026. Verfasst von Elsa Aguilar-Ancori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Immunology, Biological Science Faculty, Universidad Nacional de San Antonio Abad del Cusco, Cusco 08003, Peru. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico.
Abstract (Originalsprache)
Background
The global rise in multidrug-resistant (MDR) Gram-negative bacteria (GNB) poses an urgent challenge for infection control and antibiotic stewardship. Among these, Klebsiella pneumoniae is a major cause of hospital-acquired infections and is listed as a critical priority pathogen by the World Health Organization. Peru reports an exceptionally high prevalence of MDR K. pneumoniae, underscoring the need for innovative antimicrobial approaches.
Methods
Here, we describe the isolation and characterization of lytic Klebsiella bacteriophage from sewage samples collected from the Huatanay River (Cusco, Peru) in 2023. Phages were isolated using the reference strain MDR K. pneumoniae ATCC BAA-2814. Then, they were screened against 50 clinical MDR K. pneumoniae strains.
Results
The phage H33IIK demonstrated effective antibacterial capability, showing strict host specificity for K. pneumoniae, thermal stability, moderate pH tolerance, and high burst size. Whole-genome sequencing analysis classified it within the class Caudoviricetes, family Ackermannviridae, and genus Taipeivirus. The genomic analysis confirmed the absence of lysogeny-related, antimicrobial resistance, and virulence genes, supporting its suitability and safety for potential biotechnological applications.
Conclusions
These findings highlight phage H33IIK as a lytic agent effective against MDR K. pneumoniae. It could contribute to the development of phage-based approaches to combat MDR GNB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Microbiology and Immunology, Biological Science Faculty, Universidad Nacional de San Antonio Abad del Cusco, Cusco 08003, Peru.
- Laboratory of Molecular Microbiology and Biotechnology, Biological Science Faculty, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
- Laboratory of Virology and Clinical Molecular, Biological Science Faculty, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.
ORCID-Profile: Elsa Aguilar-Ancori, Abraham Espinoza-Culupú, Enrique Mamani-Zapana
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
Zitieren
APA
Aguilar-Ancori, E., Marin-Carrasco, M., Nuñez-Carazas, D., Espinoza-Culupú, A., Ramirez, P., & Mamani-Zapana, E. (2026). Isolation and Characterization of a Klebsiella Phage H33IIK Targeting Multidrug-Resistant Klebsiella pneumoniae in Peru. Antibiotics, 15(4), 365. https://doi.org/10.3390/antibiotics15040365
Vancouver
Aguilar-Ancori E, Marin-Carrasco M, Nuñez-Carazas D, Espinoza-Culupú A, Ramirez P, Mamani-Zapana E. Isolation and Characterization of a Klebsiella Phage H33IIK Targeting Multidrug-Resistant Klebsiella pneumoniae in Peru. Antibiotics. 2026;15(4):365. doi:10.3390/antibiotics15040365
BibTeX
@article{AguilarAncori2026,
author = {Aguilar-Ancori, Elsa and Marin-Carrasco, Marishani and Nuñez-Carazas, Duly and Espinoza-Culupú, Abraham and Ramirez, Pablo and Mamani-Zapana, Enrique},
title = {Isolation and Characterization of a Klebsiella Phage H33IIK Targeting Multidrug-Resistant Klebsiella pneumoniae in Peru},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {4},
pages = {365},
doi = {10.3390/antibiotics15040365}
}
EUVIMED